- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06828094
Enteral Nutrition and Immune Proteins Study (ENIP)
February 13, 2025 updated by: Bernadette White, University of Glasgow
The Effect of Exclusive and Partial Enteral Nutrition on Inflammation-related Proteins and on the Gut Microbiome of Healthy Adults
Eligible healthy adults who consent to take part in the study will be randomised to receive either a specialised milkshake for all of their normal daily diet (exculsive enteral nutrition, EEN) or the same specialised milkshake for half of their normal daily diet (partial enteral nutrition, PEN) for seven days.
This randomisation is to prevent any bias.
In the week before the allocated diet starts participants will be asked to give a weight and height measurement, blood sample, collect a stool and urine sample, and complete a food diary of everything they eat and drink using household measurements (e.g., a teaspoon) seven, four, and one day before the randomly allocated diet begins.
Participants will also be asked to give a weight measurement, blood sample, and collect a stool and urine sample before they start the allocated diet.
All participants will be asked to collect a third stool, urine, and blood sample and weight measurement at the end of the seven days dietary intervention.
Blood samples collected during the study will be used to find out how the cells and proteins which instruct the immune system change during the special milkshake diet.
Stool and urine samples will be used to measure the levels of different bacteria which naturally live inside the gut and how their behaviour might have changed during the diet.
Those allocated to have PEN will be asked to complete a second set of food diaries for three days during your seven days of specialised milkshake.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Glasgow, United Kingdom
- University of Glasgow
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Healthy adults (>/= 18 years)
Exclusion Criteria:
- Those sufferring from acute or chronic illness (defined as illness which requires regular visits to health services)
- Those who have experienced weight changes +/- 2kg in the past month.
- Previous gut surgery,
- Use of antibiotics or steroids in the past month
- Food allergies which prevent consumption of the enteral nutrition used (milk protein allergy)
- Current pregnancy or breastfeeding.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Exclusive Enteral Nutrition
Replacement of 100% of a participants daily energy intake with enteral nutrition for seven days
|
Nutritionally complete liquid diet used in the study to replace all (exclusive enteral nutrition) or half (partial enteral nutrition) of a participants daily energy intake
|
|
Experimental: Partial Enteral Nutrition
Replacement of 50% of a participants daily energy intake with enteral nutrition for seven days
|
Nutritionally complete liquid diet used in the study to replace all (exclusive enteral nutrition) or half (partial enteral nutrition) of a participants daily energy intake
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Inflammation-Related Proteins
Time Frame: Seven days
|
The main outcome measure of this study is to determine changes in inflammation-related proteins in the peripheral blood in response to the seven day dietary intervention.
|
Seven days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Immune Cell Populations
Time Frame: Seven days
|
One of the secondary outcome measures is to explore changes in immune cell popultions within the peripheral blood in response to the seven day dietary intervention.
|
Seven days
|
|
Changes in Gut Microbiome Composition
Time Frame: Seven days
|
One of the secondary outcome measures is to explore changes in composition of the gut microbiome in response to the seven day dietary intervention.
|
Seven days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2023
Primary Completion (Estimated)
November 21, 2025
Study Completion (Estimated)
November 21, 2025
Study Registration Dates
First Submitted
February 10, 2025
First Submitted That Met QC Criteria
February 13, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 13, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 200220086
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Adults
-
Aix Marseille UniversitéNot yet recruitingHealthy Young Adults | Healthy Older AdultsFrance
-
Fundacion Clinic per a la Recerca BiomédicaNot yet recruitingHealthy Adult Participants | Non-smoking, Healthy Adults | Normal Weight AdultsSpain
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
KU LeuvenCompletedHealthy Older Adults | Ill Older AdultsBelgium
-
Samsung Medical CenterTerminatedHealthy Aging | Healthy AdultsKorea, Republic of
-
King Abdulaziz UniversityUniversity College Dublin; Royal College of Surgeons, IrelandRecruitingHealthy Adults | Healthy NutritionSaudi Arabia
-
Balgrist University HospitalNot yet recruiting
-
Essilor InternationalRecruiting
-
University of PennsylvaniaNational Institute on Aging (NIA)Not yet recruiting
-
MinicircleRecruiting
Clinical Trials on enteral nutrition
-
University of Alabama at BirminghamActive, not recruitingEnteral Feeding Intolerance | Premature; Infant, Light-for-datesUnited States
-
Second Affiliated Hospital, School of Medicine,...Unknown
-
Nanjing University School of MedicineJinling Hospital, ChinaCompletedAcute Pancreatitis | Intra-abdominal HypertensionChina
-
Hacettepe UniversityAnkara Training and Research HospitalCompletedDiabetes Mellitus | Glycaemia | Glycemic Control for Diabetes MellitusTurkey
-
Centre Hospitalier Departemental VendeeInstitut National de la Santé Et de la Recherche Médicale, France; Ministry... and other collaboratorsCompletedShock | Acute Respiratory FailureFrance
-
Shaikh Zayed Hospital, LahoreRecruitingUncomplicated Acute Appendicitis in ChildrenPakistan
-
Shanghai Zhongshan HospitalRenJi Hospital; Shanghai 10th People's Hospital; Shanghai Tong Ren Hospital; Xinhua... and other collaboratorsSuspended
-
Société des Produits Nestlé (SPN)Completed
-
Ruijin HospitalRenJi HospitalUnknown
-
Centre Hospitalier Departemental VendeeInstitut National de la Santé Et de la Recherche Médicale, France; Ministry... and other collaboratorsTerminatedShock | Acute Respiratory FailureFrance